Sabesp and EMAE Proceed With Merger Vote Despite Lawsuit
Sabesp and EMAE confirm they will proceed with their July 30, 2026, merger votes despite regulatory and legal pushback from minority shareholders.
Brazilian water utility Companhia de Saneamento Básico do Estado de São Paulo (B3: SBSP3; NYSE: SBS) and power generator Empresa Metropolitana de Águas e Energia (B3: EMAE3) have confirmed they will proceed with their scheduled Extraordinary General Meetings (EGMs) on July 30, 2026. The decision to move forward with the vote to incorporate EMAE into Sabesp comes despite a formal request for postponement submitted to the Brazilian Securities Commission (CVM) by a minority preferred shareholder, alongside a separate judicial injunction request.
The corporate mechanism driving this transaction is a share-for-share merger in which EMAE shareholders are slated to receive 1.3195 Sabesp common shares for each EMAE share they hold. However, dissenting minority shareholders who oppose the deal face a steep discount. Under Brazilian corporate law, dissenting holders are entitled to withdrawal rights at a book value of approximately R$16.79 per share as of March 31, 2026. This is significantly lower than the R$61.85 per share Sabesp paid to acquire its controlling stake earlier in 2026, fueling the legal and regulatory pushback from minority investors.
This friction has injected immediate volatility into B3 stocks, creating a potential premium-to-discount trading gap as the July 30, 2026, vote approaches. Arbitrageurs are closely monitoring the spread between the local equities and the broader Brazil stock market today. The benchmark Ibovespa today is holding flat at 175,334.45 points, while major market drivers show mixed results: Petrobras (PETR4) is down 2.84% to R$41.01, Vale (VALE3) is up 0.60% to R$75.69, and Itaú Unibanco (ITUB4) is up 1.40% to R$42.69.
For global investors looking to invest in Brazil or trading the liquid Brazil ETF (NYSE Arca: EWZ), the immediate focus remains on whether the CVM or local courts will intervene before the scheduled July 30 meetings. While Sabesp and EMAE have stated that no active injunctions currently block the EGMs, any last-minute regulatory delay by the CVM could sharply impact short-term valuations and the broader USD BRL exchange rate dynamics.